---
title: "LACASSE LOUIS P — Ownership Dossier"
canonical: https://whiteintel.dev/entity/62f4e8cd-a360-5293-8a00-45984413e45b
json: https://whiteintel.dev/api/public/dossier/62f4e8cd-a360-5293-8a00-45984413e45b
identifier: sec:0001216489
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LACASSE LOUIS P

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001216489`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/62f4e8cd-a360-5293-8a00-45984413e45b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/62f4e8cd-a360-5293-8a00-45984413e45b  

## Ownership & control

### Holdings / subsidiaries

- **CONATUS PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/a0f384b3-47fd-5719-bb2e-2f8165c2dadb
- **Armata Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/e487a6f2-7404-56dd-9b39-fe7729fe1928

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LACASSE LOUIS P**. Human view: https://whiteintel.dev/entity/62f4e8cd-a360-5293-8a00-45984413e45b · Structured JSON: https://whiteintel.dev/api/public/dossier/62f4e8cd-a360-5293-8a00-45984413e45b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._